- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00717665
Self-monitoring of Blood Pressure in Primary Care
Self-monitoring of Blood Pressure in Primary Care in Older Diabetic Patients With Uncontrolled Systolic Hypertension
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypertension is a major risk factor for renal and cardiovascular disease (CVD). While the health benefits of lowering blood pressure (BP) are well documented, population surveys have consistently found that less than a quarter of hypertensive patients have their BP under good control. Self-monitoring of BP at home has been extensively evaluated as a potentially useful tool to improve BP control and medication adherence in hypertensive patients.
We developed a user-centric home BP tele-management system. The system captures all home self-measured BP readings and requires patients to set jointly with their physician their BP treatment goal, home BP monitoring schedule and BP alert levels. The system tracks the frequency, date and time of home readings, generates messages for patients and reports for physicians indicating whether the BP treatment goal has been reached, and sends BP alerts and adherence reminders for BP readings to patients and clinical BP alerts and reports to physicians. Using an open, randomized controlled parallel group trial design, older diabetic patients with uncontrolled systolic hypertension, recruited from the practice of primary care physicians, will receive either usual care approach to home BP monitoring or care that incorporates the use of the home BP tele-management system. The primary outcome measure is the change in mean daytime systolic BP from baseline to the last (12-month) visit on 24-hour ambulatory. The secondary objective is to examine the psychosocial factors that may make it difficult for some patients to monitor their blood pressure at home. The rationale for including a psychological component in the study is that a critical component of the system is adherence to self-monitoring. While adherence can be automatically determined through the telemanagement system, the determinants of adherence to this behaviour have not been adequately assessed in the literature. To gain insights into this aspect of health behaviour we will measure psychological predictors using quantitative and qualitative techniques. Moreover, monitoring adherence with home BP monitoring will provide a proxy measure of acceptance of the system as a poor adherence rate would suggest that patients perceive it as a futile exercise, not leading to any changes in their care.
This study tests a novel approach to treat hypertension, a major health problem in diabetic patients. The information from this study will be invaluable for future health care planning.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X5
- Mount Sinai Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of type 2 diabetes mellitus (the onset of diabetes must have occurred on or after the age of 30 years and there is no history of diabetic ketoacidosis)
- Uncontrolled systolic hypertension (defined as a daytime systolic BP of 130 mm Hg or higher on 24-hour ambulatory)
Exclusion Criteria:
- Conditions making the patient unsuitable for study such as severe cognitive impairment, language difficulties (unable to speak and understand instructions in English), frequent (more than once per month for more than week) or prolonged (more than 2 months) trips away from home, homelessness, self-identified substance abuse, being pregnant, or unable to use home BP device;
- Life expectancy less than one year
- Coexisting conditions that require frequent (more than once a month) office visits or repeated (more than once in the past year) hospitalizations
- Atrial fibrillation or other cardiac arrhythmias requiring drug treatment
- Moderately severe chronic renal failure defined as estimated GFR less than 25 mL/min
- Myocardial infarction, episode of heart failure requiring hospitalization, or paralyzing stroke in the past year
- Having unstable angina
- Severe valvular heart diseases such as severe aortic stenosis
- Symptomatic orthostatic hypotension
- Refusal to sign consent form or to carry out the demands made by the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A, 1, I
|
Scheduled blood pressure monitoring with transmission of information to a central server for processing and disbursement.
|
|
Active Comparator: A, 2, I
|
Patient self-monitoring of blood pressure with results taken by patient to the doctor at scheduled visits.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The change in mean daytime systolic BP from baseline to the last (12-month) visit on 24-hour ambulatory.
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
mean change in systolic and diastolic BP on 24-hour ambulatory and one-week home BP monitoring
Time Frame: from the baseline to the last (12-month) visit
|
from the baseline to the last (12-month) visit
|
|
mean change in daytime diastolic BP on 24-hour ambulatory BP monitoring
Time Frame: from the baseline to the last (12-month) visit
|
from the baseline to the last (12-month) visit
|
|
mean change in systolic and diastolic BP during the sleep period on 24-hour ambulatory BP monitoring
Time Frame: from the baseline to the last (12-month) visit
|
from the baseline to the last (12-month) visit
|
|
the proportion of patients at systolic BP goal, defined as <130 mmHg and diastolic BP goal, defined as <80 mm Hg, based on the 24-hour ambulatory BP and one-week home BP monitoring recording
Time Frame: one year
|
one year
|
|
number and doses of different classes of antihypertensive medications
Time Frame: one year
|
one year
|
|
average adherence rate with home BP monitoring
Time Frame: one year
|
one year
|
|
the number of adherence reminders in the tele-management group over the course of the study
Time Frame: one year
|
one year
|
|
the number of office visits of patients
Time Frame: during the one year study period
|
during the one year study period
|
|
determinants of adherence to tele-monitoring
Time Frame: one year
|
one year
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Alexander G. Logan, MD, FRCP(C), Mount Sinai Hospital
Publications and helpful links
General Publications
- Logan AG, McIsaac WJ, Tisler A, Irvine MJ, Saunders A, Dunai A, Rizo CA, Feig DS, Hamill M, Trudel M, Cafazzo JA. Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients. Am J Hypertens. 2007 Sep;20(9):942-8. doi: 10.1016/j.amjhyper.2007.03.020.
- Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003 Nov 8;362(9395):1527-35. doi: 10.1016/s0140-6736(03)14739-3.
- Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004 Jan;43(1):10-7. doi: 10.1161/01.HYP.0000103630.72812.10. Epub 2003 Nov 24.
- Logan AG, Irvine MJ, McIsaac WJ, Tisler A, Rossos PG, Easty A, Feig DS, Cafazzo JA. Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics. Hypertension. 2012 Jul;60(1):51-7. doi: 10.1161/HYPERTENSIONAHA.111.188409. Epub 2012 May 21.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ESA 5970
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Blood Pressure
-
Indena S.p.ARecruitingHigh-normal Blood PressureItaly
-
GE HealthcareTerminatedBlood Pressure (Low, Normal, High)United States
-
Dow University of Health SciencesCompletedCognitive Change | Blood Pressure | Blood Glucose, HighPakistan
-
The Cleveland ClinicNot yet recruitingHypertension | Blood Pressure, High | Hypertension (HTN) | Blood Pressure ControlUnited States
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Centre Hospitalier Universitaire de la GuadeloupeRecruiting
-
Ouraring Inc.Recruiting
-
The University of NorthamptonCompletedHypertension | Blood Pressure, HighUnited Kingdom
Clinical Trials on Home blood pressure tele-management system.
-
University of Maryland, BaltimoreTerminated
-
University of British ColumbiaNot yet recruitingHypertension
-
MedStar Georgetown University HospitalMedstar Health Research InstituteUnknownHypertension | Ischemic StrokeUnited States
-
Icahn School of Medicine at Mount SinaiAgency for Healthcare Research and Quality (AHRQ)Completed
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
Hao YonggangRecruiting
-
Oslo University HospitalTerminatedCardiovascular Diseases | Hypertension | Kidney Transplant; ComplicationsNorway
-
University of AarhusRigshospitalet, Denmark; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsCompletedAcute Ischemic StrokeDenmark
-
Jennifer Lewey, MD, MPHPatient-Centered Outcomes Research InstituteRecruitingHypertension, Pregnancy InducedUnited States
-
Boryung Pharmaceutical Co., LtdCompletedHypertensionKorea, Republic of